Dexmedetomidine reduces oxidative stress and provides neuroprotection in a model of traumatic brain injury via the PGC-1α signaling pathway
Authors:
Open Access
- 1 December 2018
- journal article
- research article
- Published by Elsevier in Neuropeptides
- Vol. 72, 58-64
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Traumatic Brain Injury and NADPH Oxidase: A Deep RelationshipOxidative Medicine and Cellular Longevity, 2015
- Luteolin provides neuroprotection in models of traumatic brain injury via the Nrf2–ARE pathwayFree Radical Biology and Medicine, 2014
- Upregulation of PGC‐1α expression by Alzheimer's disease‐associated pathway: presenilin 1/amyloid precursor protein (APP)/intracellular domain of APPAging Cell, 2013
- The expression of PGC-1αin the mice brain after traumatic brain injuryBrain Injury, 2012
- Activation of Akt/GSK-3beta/beta-catenin signaling pathway is involved in survival of neurons after traumatic brain injury in ratsNeurological Research, 2012
- Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a ‘mitohormesis’ mechanism involving reactive oxygen species and PGC-1European Heart Journal, 2011
- PGC-1α Regulates Expression of Myocardial Mitochondrial Antioxidants and Myocardial Oxidative Stress After Chronic Systolic OverloadAntioxidants & Redox Signaling, 2010
- Mouse closed head injury model induced by a weight-drop deviceNature Protocols, 2009
- Dexmedetomidine Increases Hippocampal Phosphorylated Extracellular Signal–regulated Protein Kinase 1 and 2 Content by an α2-Adrenoceptor–independent MechanismAnesthesiology, 2008
- SIRT1/PGC-1médecine/sciences, 2007